1 Market Overview
1.1 Product Overview and Scope of Anti-erectile Dysfunction (ED) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sildenafil (Viagra)
1.3.3 Vardenafil (Levitra, Staxyn)
1.3.4 Tadalafil (Cialis)
1.3.5 Avanafil (Stendra)
1.3.6 Udenafil (Zydena)
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Clinic
1.4.5 Online Pharmacy
1.5 Global Anti-erectile Dysfunction (ED) Drugs Market Size & Forecast
1.5.1 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity (2018-2029)
1.5.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Vivus, Inc.
2.1.1 Vivus, Inc. Details
2.1.2 Vivus, Inc. Major Business
2.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product and Services
2.1.4 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Vivus, Inc. Recent Developments/Updates
2.2 Lilly ICOS LLC
2.2.1 Lilly ICOS LLC Details
2.2.2 Lilly ICOS LLC Major Business
2.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product and Services
2.2.4 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lilly ICOS LLC Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Product and Services
2.3.4 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Product and Services
2.4.4 Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Recent Developments/Updates
2.5 Hims
2.5.1 Hims Details
2.5.2 Hims Major Business
2.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Product and Services
2.5.4 Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hims Recent Developments/Updates
2.6 Menarini Group
2.6.1 Menarini Group Details
2.6.2 Menarini Group Major Business
2.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product and Services
2.6.4 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Menarini Group Recent Developments/Updates
2.7 Lupin
2.7.1 Lupin Details
2.7.2 Lupin Major Business
2.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Product and Services
2.7.4 Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lupin Recent Developments/Updates
2.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
2.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Details
2.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
2.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product and Services
2.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
2.9 General Factory
2.9.1 General Factory Details
2.9.2 General Factory Major Business
2.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Product and Services
2.9.4 General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 General Factory Recent Developments/Updates
2.10 CSBio
2.10.1 CSBio Details
2.10.2 CSBio Major Business
2.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Product and Services
2.10.4 CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CSBio Recent Developments/Updates
2.11 Dong-A ST
2.11.1 Dong-A ST Details
2.11.2 Dong-A ST Major Business
2.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product and Services
2.11.4 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Dong-A ST Recent Developments/Updates
2.12 Metuchen Pharma
2.12.1 Metuchen Pharma Details
2.12.2 Metuchen Pharma Major Business
2.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
2.12.4 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Metuchen Pharma Recent Developments/Updates
2.13 Seoul Pharma
2.13.1 Seoul Pharma Details
2.13.2 Seoul Pharma Major Business
2.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
2.13.4 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Seoul Pharma Recent Developments/Updates
2.14 Teva Pharma
2.14.1 Teva Pharma Details
2.14.2 Teva Pharma Major Business
2.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
2.14.4 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Teva Pharma Recent Developments/Updates
2.15 S.K. Chemicals
2.15.1 S.K. Chemicals Details
2.15.2 S.K. Chemicals Major Business
2.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product and Services
2.15.4 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 S.K. Chemicals Recent Developments/Updates
3 Competitive Environment: Anti-erectile Dysfunction (ED) Drugs by Manufacturer
3.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-erectile Dysfunction (ED) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-erectile Dysfunction (ED) Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-erectile Dysfunction (ED) Drugs Manufacturer Market Share in 2022
3.5 Anti-erectile Dysfunction (ED) Drugs Market: Overall Company Footprint Analysis
3.5.1 Anti-erectile Dysfunction (ED) Drugs Market: Region Footprint
3.5.2 Anti-erectile Dysfunction (ED) Drugs Market: Company Product Type Footprint
3.5.3 Anti-erectile Dysfunction (ED) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-erectile Dysfunction (ED) Drugs Market Size by Region
4.1.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2018-2029)
4.2 North America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.3 Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.5 South America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
5.2 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type (2018-2029)
5.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
6.2 Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application (2018-2029)
6.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
7.2 North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
7.3 North America Anti-erectile Dysfunction (ED) Drugs Market Size by Country
7.3.1 North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Anti-erectile Dysfunction (ED) Drugs Market Size by Country
8.3.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
10.2 South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
10.3 South America Anti-erectile Dysfunction (ED) Drugs Market Size by Country
10.3.1 South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-erectile Dysfunction (ED) Drugs Market Drivers
12.2 Anti-erectile Dysfunction (ED) Drugs Market Restraints
12.3 Anti-erectile Dysfunction (ED) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-erectile Dysfunction (ED) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-erectile Dysfunction (ED) Drugs
13.3 Anti-erectile Dysfunction (ED) Drugs Production Process
13.4 Anti-erectile Dysfunction (ED) Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-erectile Dysfunction (ED) Drugs Typical Distributors
14.3 Anti-erectile Dysfunction (ED) Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Vivus, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Vivus, Inc. Major Business
Table 5. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 6. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Vivus, Inc. Recent Developments/Updates
Table 8. Lilly ICOS LLC Basic Information, Manufacturing Base and Competitors
Table 9. Lilly ICOS LLC Major Business
Table 10. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 11. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Lilly ICOS LLC Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 16. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 21. Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Recent Developments/Updates
Table 23. Hims Basic Information, Manufacturing Base and Competitors
Table 24. Hims Major Business
Table 25. Hims Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 26. Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hims Recent Developments/Updates
Table 28. Menarini Group Basic Information, Manufacturing Base and Competitors
Table 29. Menarini Group Major Business
Table 30. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 31. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Menarini Group Recent Developments/Updates
Table 33. Lupin Basic Information, Manufacturing Base and Competitors
Table 34. Lupin Major Business
Table 35. Lupin Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 36. Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lupin Recent Developments/Updates
Table 38. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
Table 40. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 41. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
Table 43. General Factory Basic Information, Manufacturing Base and Competitors
Table 44. General Factory Major Business
Table 45. General Factory Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 46. General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. General Factory Recent Developments/Updates
Table 48. CSBio Basic Information, Manufacturing Base and Competitors
Table 49. CSBio Major Business
Table 50. CSBio Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 51. CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CSBio Recent Developments/Updates
Table 53. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 54. Dong-A ST Major Business
Table 55. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 56. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Dong-A ST Recent Developments/Updates
Table 58. Metuchen Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Metuchen Pharma Major Business
Table 60. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 61. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Metuchen Pharma Recent Developments/Updates
Table 63. Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Seoul Pharma Major Business
Table 65. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 66. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Seoul Pharma Recent Developments/Updates
Table 68. Teva Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Teva Pharma Major Business
Table 70. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 71. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Teva Pharma Recent Developments/Updates
Table 73. S.K. Chemicals Basic Information, Manufacturing Base and Competitors
Table 74. S.K. Chemicals Major Business
Table 75. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 76. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. S.K. Chemicals Recent Developments/Updates
Table 78. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Anti-erectile Dysfunction (ED) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Anti-erectile Dysfunction (ED) Drugs Production Site of Key Manufacturer
Table 83. Anti-erectile Dysfunction (ED) Drugs Market: Company Product Type Footprint
Table 84. Anti-erectile Dysfunction (ED) Drugs Market: Company Product Application Footprint
Table 85. Anti-erectile Dysfunction (ED) Drugs New Market Entrants and Barriers to Market Entry
Table 86. Anti-erectile Dysfunction (ED) Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Anti-erectile Dysfunction (ED) Drugs Raw Material
Table 146. Key Manufacturers of Anti-erectile Dysfunction (ED) Drugs Raw Materials
Table 147. Anti-erectile Dysfunction (ED) Drugs Typical Distributors
Table 148. Anti-erectile Dysfunction (ED) Drugs Typical Customers
List of Figures
Figure 1. Anti-erectile Dysfunction (ED) Drugs Picture
Figure 2. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Type in 2022
Figure 4. Sildenafil (Viagra) Examples
Figure 5. Vardenafil (Levitra, Staxyn) Examples
Figure 6. Tadalafil (Cialis) Examples
Figure 7. Avanafil (Stendra) Examples
Figure 8. Udenafil (Zydena) Examples
Figure 9. Others Examples
Figure 10. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Application in 2022
Figure 12. Hospital Examples
Figure 13. Retail Pharmacy Examples
Figure 14. Clinic Examples
Figure 15. Online Pharmacy Examples
Figure 16. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity (2018-2029) & (K Units)
Figure 19. Global Anti-erectile Dysfunction (ED) Drugs Average Price (2018-2029) & (US$/Unit)
Figure 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Anti-erectile Dysfunction (ED) Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Anti-erectile Dysfunction (ED) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Anti-erectile Dysfunction (ED) Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 58. China Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Anti-erectile Dysfunction (ED) Drugs Market Drivers
Figure 79. Anti-erectile Dysfunction (ED) Drugs Market Restraints
Figure 80. Anti-erectile Dysfunction (ED) Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Anti-erectile Dysfunction (ED) Drugs in 2022
Figure 83. Manufacturing Process Analysis of Anti-erectile Dysfunction (ED) Drugs
Figure 84. Anti-erectile Dysfunction (ED) Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source

※参考情報 抗勃起不全（ED）治療薬は、勃起不全という男性特有の性機能障害を改善するために使用される薬剤です。勃起不全は、性的興奮があったにもかかわらず持続的な勃起が得られない、または十分な勃起が維持できない状態を指します。この問題は、スティグマや恥ずかしさから多くの男性が相談をためらうことが多いですが、EDは一般的な健康問題であり、様々な年齢層の男性が影響を受ける可能性があります。 抗勃起不全治療薬の主な定義としては、ペニスへの血流を増加させ、勃起を助けることを目的とした薬剤群を指します。これらの薬剤は、主に陰茎海綿体の平滑筋を弛緩させることによって血液の流入を増加させます。通常、性的刺激がないと効果を発揮しないため、自然な性的興奮が求められます。 抗勃起不全治療薬にはいくつかの特徴があります。まず、効果の発現時間や持続時間に違いがあります。いくつかの薬剤は服用後すぐに効果を発揮しますが、他のものは数時間遅れて効果を示します。また、服用後数時間から数日間効果が持続するものもあり、患者のライフスタイルやセクシュアルなニーズに応じて適切な選択が可能です。副作用、相互作用、禁忌事項についても多様性があるため、医師との相談が重要です。 抗勃起不全治療薬の代表的な種類としては、シルデナフィル（商品名：バイアグラ）、タダラフィル（商品名：シアリス）、バルデナフィル（商品名：レビトラ）、アバナフィル（商品名：ストエンス）が挙げられます。シルデナフィルは1998年にFDAに承認され、最初の抗ED薬として知られています。タダラフィルは、週に1回服用することで継続的な効果を得られる特徴があり、特にセクシュアルな自由度が求められる生活スタイルを持つ方に適しています。バルデナフィルは、食事の影響を受けにくく、素早い効果が期待できるため、使用するタイミングを柔軟に選べる利点があります。アバナフィルは、比較的新しい薬剤で、速やかな効果を発揮しつつ副作用が少ないことから、人気があります。 抗勃起不全治療薬の主な用途は、勃起不全を改善することです。EDは身体的、心理的、あるいはその両方の要因によって起こることがあり、これらの薬剤は特に身体的要因に起因する場合に効果的です。糖尿病、高血圧、心血管疾患、神経障害等がEDの原因となることが多いため、これらの持病を持つ男性にとって重要な治療選択肢となります。また、心理的な要因が関与している場合でも、薬物療法によって自信を回復し、より積極的な性的体験をもたらすことができる場合があります。 抗ED薬は、他の治療法と併用することも可能です。心理療法やカップルセラピー、生活習慣の改善など、総合的なアプローチが推奨される場合もあります。また、最近ではマイクロ波や超音波治療、真空ポンプ、ペニスインプラントなどの非薬物療法も注目されています。これらは、特に薬剤に反応がない場合や、重度のED患者において考慮されます。 関連技術についても言及すると、バイオテクノロジーの進展により、新たな治療法の開発が進められています。例えば、幹細胞治療や遺伝子療法は、将来的に新たな対策として期待されています。また、ナノテクノロジーを利用したドラッグデリバリーシステムなども研究されています。 抗勃起不全治療薬は、多くの男性にとって生活の質を向上させ、自信を取り戻すための重要な治療オプションです。ただし、全てのED患者に対して効果があるわけではなく、専門的な診断と治療が必要です。個々の症状やライフスタイルに合った最適な薬剤を選ぶためには、医療機関での相談が不可欠です。 医師は、適切な評価を行った上で、患者にとって最も効果的で安全な治療法を提案します。また、薬剤の服用に際しては、他の薬剤との相互作用にも注意が必要です。特に、ニトログリセリン系の薬剤を服用している患者に対しては、抗ED薬の使用は禁忌となります。これらの副作用や禁忌を理解し、患者自身が保護されるような治療が行われることが重要です。 最後に、勃起不全は多くの男性に影響を与える一般的な問題ですが、その治療にはまだ多くの誤解や偏見が存在します。抗勃起不全治療薬は、こうした問題を克服するための重要な手段であり、今後も研究と技術開発が進むことで、さらに多くの選択肢が提供されることが期待されます。このような情報を理解し、適切な治療を受けることで、多くの男性がより充実した性生活を享受できるようになることが望まれます。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/